Skip to main content
Psychedelic State(s) of America
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Newsfilecorp

Published November 3, 2026 · Updated November 4, 2026

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 ... - Newsfile Corp.

Read the full story at Newsfilecorp

Psychedelic Therapy Trial. November 03, 2026 8:02 AM EST | Source ... This press release contains certain "forward-looking information.

Post on X

Share this story

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal

Surfaced by 3 Google Alerts

  • Psychedelic press release
  • Psychedelics
  • Ibogaine